ANGELO LEWIS: Open Payments
NPI 1669142527 · ORLANDO, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,711 in 104 payments from 18 companies in 2025. Trend: 2023 $2,934 · 2024 $3,170 · 2025 $2,711
Food & beverage: $2,602Education: $109
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 23 | $573 |
| Janssen Biotech, Inc. | 19 | $341 |
| Intra-Sana Laboratories | 3 | $307 |
| Takeda Pharmaceuticals U.S.A., Inc. | 7 | $252 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 13 | $171 |
| Madrigal Pharmaceuticals | 8 | $168 |
| Regeneron Healthcare Solutions, Inc. | 3 | $165 |
| Lilly USA, LLC | 8 | $159 |
| Ardelyx, Inc. | 5 | $150 |
| QOL Medical, LLC | 3 | $129 |
Products named: TREMFYA, RELTONE 200 MG, SKYRIZI, ENTYVIO, REZDIFFRA, DUPIXENT, OMVOH, IBSRELA.
Industry payments across FL — which companies pay providers there.
